miR‐133b as a potential regulator of a synaptic NPTX2 protein in Alzheimer's disease

Abstract

Abstract A synaptic protein, Neuronal Pentraxin 2 (NPTX2), has emerged as a pivotal biomarker for Alzheimer's dementia (AD). We identified candidate miRNAs targeting NPTX2 and performed association and mediation analyses using multi‐omics data (N = 702). Among 44 candidate miRNAs, miR‐133b was significantly associated with AD and Braak positivity. Higher miR‐133b expression was also associated with higher NPTX2 gene expression and better cognition. Mediation analysis showed that miR‐133b partially influences AD and cognition through the NPTX2 protein. Our integrated approach suggests a potential role of miR‐133b in synaptic integrity and offers new insights into AD pathogenesis.